Public hospital hires cancer specialist

HSA’s medical oncologist Dr. Basil Armonis, center, with chemotherapy nurses Rosanna Humphreys-Johnson and Andrew Ward.

The Health Services Authority has hired Dr. Basil Armonis as a full-time oncologist at the Cayman Islands Hospital as part of efforts to enhance cancer care services at the hospital.

Dr. Armonis, who is originally from Athens, Greece, said, “It is a pleasure to be a part of the HSA team, and to be able to help patients in the Cayman Islands receive the care that they need and deserve close to home.

“Reducing the travel time for patients exposes them to less physical as well as less psychological distress, allowing them more time to focus on healing and also spending quality time with family and friends doing the things that they enjoy doing.”

Before Dr. Armonis’ employment, Dr. Gillian Wharfe, a visiting oncologist/hematologist, traveled from Jamaica at least once a month to treat patients. Dr. Wharfe, who has been working with the HSA since 2002, will continue to provide medical care for patients with hematological conditions.

“Utilizing the best medical equipment and technology science has to offer is just one aspect of quality medical oncology and cancer care. The other part, which is even more important, is the ability to deliver the best care possible in a way that is timely, accessible and efficient,” said HSA Medical Director Dr. Delroy Jefferson.

“Having Dr. Armonis, who has a wealth of knowledge and experience in oncology, helps us to achieve this. It is what people in our community diagnosed with cancer need and deserve from their primary provider of healthcare services.”

Dr. Armonis received his medical degree from the University of Rome, Italy and completed his fellowship in medical oncology at the University College of London Hospital in the U.K. In 1996, he obtained the European Certification in medical oncology. Dr. Armonis holds a second specialization in internal medicine and full registration as well as specialist registration in medical oncology with the U.K.’s General Medical Council.